Drugs Made In America Acquisition Corp. Units Cash Flow Reinvestment Rate
Drugs Made In America Acquisition Corp. Units cash flow reinvestment rate. Drugs Made In America Acquisition Corp. Units (DMAAU) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting $4.00 (capex $4.00 ) from operating cash flow of $137.91K. Explore debt repayment capacity of Drugs Made In America Acquisition Corp. to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Drugs Made In America Acquisition Corp. Units Cash Flow Reinvestment Rate by Year (None–None)
Drugs Made In America Acquisition Corp. Units cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Drugs Made In America Acquisition Corp. Units. For the full cash flow conversion analysis, see cash efficiency ratio of Drugs Made In America Acquisition Corp. .
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|